SevenBridge Financial Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $278K | Hold |
372
| – | – | 0.04% | 175 |
|
|
2025
Q4 | $284K | Hold |
372
| – | – | 0.05% | 172 |
|
|
2025
Q3 | $254K | Sell |
372
-25
| -6% | -$14.1K | 0.04% | 183 |
|
|
2025
Q2 | $221K | Sell |
397
-145
| -27% | -$80.9K | 0.04% | 203 |
|
|
2025
Q1 | $312K | Sell |
542
-121
| -18% | -$83.2K | 0.06% | 181 |
|
|
2024
Q4 | $441K | Sell |
663
-58
| -8% | -$48.7K | 0.08% | 154 |
|
|
2024
Q3 | $595K | Sell |
721
-10
| -1% | -$11.1K | 0.11% | 129 |
|
|
2024
Q2 | $779K | Sell |
731
-10
| -1% | -$9.69K | 0.17% | 116 |
|
|
2024
Q1 | $709K | Sell |
741
-155
| -17% | -$147K | 0.16% | 117 |
|
|
2023
Q4 | $787K | Sell |
896
-13
| -1% | -$10.7K | 0.19% | 107 |
|
|
2023
Q3 | $748K | Sell |
909
-56
| -6% | -$44K | 0.19% | 106 |
|
|
2023
Q2 | $693K | Hold |
965
| – | – | 0.18% | 109 |
|
|
2023
Q1 | $793K | Hold |
965
| – | – | 0.22% | 102 |
|
|
2022
Q4 | $696K | Hold |
965
| – | – | 0.2% | 106 |
|
|
2022
Q3 | $665K | Hold |
965
| – | – | 0.23% | 95 |
|
|
2022
Q2 | $570K | Sell |
965
-422
| -30% | -$274K | 0.23% | 89 |
|
|
2022
Q1 | $969K | Sell |
1,387
-71
| -5% | -$44.9K | 0.34% | 70 |
|
|
2021
Q4 | $921K | Buy |
1,458
+542
| +59% | +$333K | 0.28% | 86 |
|
|
2021
Q3 | $554K | Buy |
916
+55
| +6% | +$34.1K | 0.18% | 103 |
|
|
2021
Q2 | $481K | Buy |
861
+187
| +28% | +$94.7K | 0.16% | 111 |
|
|
2021
Q1 | $319K | Buy |
+674
| New | +$328K | 0.12% | 119 |
|
|
2019
Q3 | – | Sell |
-75
| Closed | -$23K | – | 477 |
|
|
2019
Q2 | $23K | Hold |
75
| – | – | 0.01% | 374 |
|
|
2019
Q1 | $31K | Hold |
75
| – | – | 0.01% | 296 |
|
|
2018
Q4 | $28K | Hold |
75
| – | – | 0.02% | 265 |
|
|
2018
Q3 | $30K | Hold |
75
| – | – | 0.02% | 292 |
|
|
2018
Q2 | $26K | Hold |
75
| – | – | 0.01% | 312 |
|
|
2018
Q1 | $26K | Hold |
75
| – | – | 0.01% | 322 |
|
|
2017
Q4 | $28K | Hold |
75
| – | – | 0.02% | 332 |
|
|
2017
Q3 | $34K | Hold |
75
| – | – | 0.02% | 303 |
|
|
2017
Q2 | $37K | Sell |
75
-75
| -50% | -$32.8K | 0.02% | 304 |
|
|
2017
Q1 | $57K | Hold |
150
| – | – | 0.04% | 233 |
|
|
2016
Q4 | $56K | Hold |
150
| – | – | 0.04% | 238 |
|
|
2016
Q3 | $56K | Hold |
150
| – | – | 0.04% | 235 |
|
|
2016
Q2 | $52K | Buy |
+150
| New | +$57.8K | 0.04% | 265 |
|
Other funds holding REGN
VCM
N
SevenBridge Financial Group's REGN Position: Q1 2026 in Review
SevenBridge Financial Group held its Regeneron Pharmaceuticals (REGN) position steady in Q1 2026 at 372 shares worth $278K. The position accounts for 0.04% of the portfolio, ranked #175.
SevenBridge Financial Group first reported a position in REGN in Q2 2016 and has held it in 34 quarters since. The position peaked at $969K in Q1 2022. 1,393 funds tracked by Wall St. Rank hold REGN as of Q1 2026.
- SevenBridge Financial Group held 372 shares of Regeneron Pharmaceuticals worth $278K as of Q1 2026.
- SevenBridge Financial Group left its Regeneron Pharmaceuticals share count unchanged in Q1 2026.
- Regeneron Pharmaceuticals made up 0.04% of SevenBridge Financial Group's portfolio in Q1 2026, its #175 holding.
- SevenBridge Financial Group first reported a position in Regeneron Pharmaceuticals in Q2 2016 and has held it in 34 quarters since.
- SevenBridge Financial Group's Regeneron Pharmaceuticals position peaked at $969K in Q1 2022.
- 1,393 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.
Based on SevenBridge Financial Group's 13F filing for Q1 2026, filed 23 Apr 2026.